Bone marrow injection at the femoral neck fracture site in young adults with intracapsular hip fractures

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study evaluates autologous bone marrow injection at the fracture site after anatomical reduction and fixation for intracapsular femoral neck fractures in young adults. The primary goals are to identify factors linked to these fractures and to see if bone marrow injection can promote complete healing, shorten recovery time, and lower avascular necrosis risk. Eligibility includes adults 18–55 with Garden type III or IV fractures within 24 hours of injury. The trial compares anatomical reduction with fixation alone versus reduction with fixation plus bone marrow injection. Conducted at Idlib University Faculty of Medicine, it aims to inform alternative strategies to minimize complications in a younger patient population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age between 18 and 55 years.
* Intracapsular femoral neck fracture classified as Garden type III or IV.
* The time elapsed since the fracture occurred must not exceed 24 hours

Exclusion Criteria:

* Age under 18 years or over 55 years.
* Open femoral neck fracture.
* Neglected femoral neck fractures or fractures that occurred more than 24 hours prior to presentation.
* Polytrauma patients who are in shock or admitted to the intensive care unit (ICU).

Where it's running

• Idlib university Faculty of medicine
  Idlib, Syria Recruiting

Study contacts

• Study coordinator: Mohamad M ISSA, MD
• Email: mohamadalessa888@gmail.com
• Phone: 0954233150

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Collarless Actis hip stem for cementless hip replacement in Asian patients

  This study tests how well a collarless Actis hip stem works in adults undergoing primary hip replacement, focusing on outcomes over five years in an East Asian population.

  Recruiting Seoul National University Bundang Hospital · Seongnam-si, Gyeonggi-do · NCT07828080

• Tipmed™ Primary Hip Prosthesis: 24-Month Post-Market Follow-Up in Adults

  This PMCF study tests the safety and 24‑month performance of the Tipmed hip prosthesis in adults undergoing primary hip replacement.

  Recruiting at 4 sites TIPMED Medical Device Manufacturing Ltd. Co. · Balıkesir and 3 other locations · NCT07651735

• Sacral ESPB versus PENG nerve block for pain after hip hemiarthroplasty

  We will see if a sacral erector spinae plane (S-ESPB) block or a pericapsular nerve group (PENG) block gives better pain relief for adults 50–90 having hip hemiarthroplasty for a femoral neck fracture.

  Recruiting Fayoum University Hospital · El Fayoum Qesm, Faiyum Governorate · NCT07442721

• How ciprofol behaves and affects older adults having limb surgery under general anesthesia

  This study tests whether ciprofol provides safe and effective anesthesia for older adults having elective limb surgery by measuring drug levels and clinical responses.

  Recruiting Shanghai Geriatric Medical Center · Shanghai · NCT07301242

• Fixation versus arthroplasty for faster recovery after minimally displaced femoral neck fractures (FASTER-HIP)

  This trial will test whether replacing the hip (arthroplasty) instead of fixing the bone (internal fixation) helps people aged 60 and older with minimally displaced femoral neck fractures recover faster, stay alive and walking, and spend more days at home over the first year.

  Recruiting at 23 sites University of Southern California · Irvine, California and 31 other locations · NCT07244211

• AI-assisted vs surgeon-planned screw paths for freehand femoral neck fixation

  This trial will test whether AI-assisted planning leads to more accurate screw placement, shorter operative time, and less radiation for adults having cannulated screw fixation of femoral neck fractures.

  Recruiting at 4 sites Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan and 3 other locations · NCT06937138

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.